CSE/TELI (CSE/TELI)

Canadian Securities Exchange: CSE/TELI · CAD

CA$0.31

+0.01 (+5.1%)· Recorded snapshot

Market cap	25.1M
Revenue (ttm)	7.3M
Net income (ttm)	-4.1M
EPS (ttm)	-CA$0.06
Shares out	80.8M
Volume	185,504
Beta	1.52

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.3M
Net income (ttm): -4.1M
EPS (ttm): -CA$0.06
Market cap: 25.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-229.3

P25 n/aP50 n/aP75 n/a

ROIC-55.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/TELI indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

CAD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-21
Enterprise value	CAD 26.4M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-05-31
First seen	2026-05-10
Fiscal year end	August
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA87953P1080
Last earnings date	2026-01-27
Last refreshed	2026-10-29
Market cap	CAD 25.1M
Next earnings date	2026-12-21
Price	CAD 0.31
Price currency	CAD
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-29
Symbol	cse/TELI
Website	https://telescopeinnovations.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-17.82%
EV/Sales	3.46x
FCF / EV yield	-24.82%
FCF yield	-26.25%
P/B ratio	7.03x
P/S ratio	3.27x
Price / tangible book value	7.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-51.42%
EBITDA margin	-42.7%
Gross margin	100%
Operating margin	-51.42%
Pretax margin	-56.03%
Profit margin	-56.03%
Profitable quarters	1
Profitable years	1
ROA	-36.56%
ROA (5Y)	-33.07%
ROCE	-69.2%
ROE	-229.34%
ROE (5Y)	-121.22%
ROIC	-55.2%
SBC / revenue	7.91%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	83.67%
Gross profit growth (Q)	18.41%
Gross profit growth 3Y	33.52%
Net income growth quarters	1
Net income growth years	1
Revenue growth	83.68%
Revenue growth (Q)	18.41%
Revenue growth (QoQ)	-20.15%
Revenue growth 3Y	35.48%
Revenue growth quarters	5
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -572,383
Depreciation and amortization	CAD 636,716
EBIT	CAD -3.8M
EBITDA	CAD -3.1M
EPS	CAD -0.06
FCF per share	CAD -0.08
Financing cash flow	CAD 6.5M
Free cash flow	CAD -6.3M
Free cash flow minus SBC	CAD -6.8M
Gross profit	CAD 7.3M
Investing cash flow	CAD -572,383
Net borrowing	CAD -242,254
Net cash flow	CAD 224,862
Net income	CAD -4.1M
Operating cash flow minus SBC	CAD -6.3M
Operating income	CAD -3.8M
Revenue	CAD 7.3M
Stock-based compensation	CAD 577,345

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.16
Book value per share	CAD 0.04
Debt / equity	0.8
Interest coverage	-13.99
Long-term assets	CAD 3.2M
Long-term liabilities	CAD 2M
Net cash (debt)	CAD -1.4M
Net cash / market cap	-5.78%
Net debt / equity	0.41
Piotroski F-Score	2
Property, plant and equipment	CAD 3.2M
Shareholders' equity	CAD 3.4M
Tangible book value	CAD 3.4M
Tangible book value per share	CAD 0.04
Total assets	CAD 6.8M
Total cash	CAD 1.3M
Total debt	CAD 2.7M
Total liabilities	CAD 3.5M
WACC	12.13%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.14
Current assets	CAD 3.7M
Current liabilities	CAD 1.4M
Current ratio	2.59
Net working capital	CAD 1.6M
Quick ratio	2.08
Working capital	CAD 2.2M
Working capital turnover	12.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-37.91%
Shareholder yield	-37.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.53
1D price change	5.08%
1M price change	-28.57%
1M total return	-28.57%
1W price change	-15.49%
1W total return	-15.49%
1Y price change	-25%
1Y return CAGR	-25.01%
1Y total return	-25%
20-day SMA	CAD 0.38
200-day SMA	CAD 0.50
3M price change	-30.23%
3M total return	-30.23%
3Y price change	36.36%
3Y return CAGR	10.89%
3Y total return	36.36%
50-day SMA	CAD 0.44
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 1.10
52-week high date	2026-05-19
52-week low	CAD 0.28
52-week low date	2026-10-29
5Y price change	-60%
5Y return CAGR	-16.75%
5Y total return	-60%
6M price change	-25%
6M total return	-25%
All-time high	CAD 1.18
All-time high date	2021-11-01
All-time low	CAD 0.13
All-time low date	2023-04-26
Average true range (ATR)	CAD 0.03
Average volume	87.3K
Beta (1Y)	0.43
Beta (2Y)	0.37
Beta (5Y)	1.52
Change from 52-week high	-71.82%
Change from 52-week low	10.71%
Change from all-time high	-74.58%
Change from all-time low	130.77%
Change from open	6.9%
Day's gap	-1.69%
Dollar volume	CAD 57,506
High price	CAD 0.31
Low price	CAD 0.28
Monthly RSI	44.41
Open price	CAD 0.29
Position in 52-week range	100%
Previous close	CAD 0.30
Price vs 150-day SMA	-43.63%
Price vs 20-day SMA	-21.11%
Price vs 200-day SMA	-39.5%
Price vs 50-day SMA	-31.86%
Relative volume	2.12
RSI	25.71
Sharpe ratio	0.27
Sharpe ratio (3Y)	0.52
Sortino ratio	0.5
Sortino ratio (3Y)	0.89
Volume	185.5K
Weekly RSI	36.09
YTD price change	-16.67%
YTD total return	-16.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68.6M
Shares change (QoQ)	0%
Shares change (YoY)	37.91%
Shares held by insiders	15.11%
Shares outstanding	80.8M

Deeper analysis on CSE/TELI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/TELI report

Is a complete CSE/TELI research report available?

No complete published report is available for cse/TELI (CSE/TELI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/TELI (CSE/TELI)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/TELI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/TELI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/TELI

Frequently asked questions